Contributors to US Excessive Drug Pricing
Research - Drug pricing in the US is not a straightforward process. For the most part, this is done by design. Politicians and media have put the … Continue Reading
Read nowAuthor Archives: Editorial Staff
Combos Could be Next Paradigm in Obesity Treatments
Insights - With Thanksgiving weekend here, food is atop the mind of all Americans. We thought it only appropriate to give an update on the obesity field. … Continue Reading
Read now
Radiopharmaceutical Space Rolling as Eli Lilly Acquires Point
Research - This morning, Eli Lilly (LLY) acquired Point Bio (PNT) for $12.50/share, an 87% premium. The $1.4B price tag gives Lilly a strong presence in radiopharmaceuticals … Continue Reading
Read now
Structure (GPCR) Rallies on Oral GLP-1 & Abbott Claims CGM Tech A Companion to GLP
Insights - Structure Therapeutics (GPCR) is up more than 35% this morning after announcing Phase 1b data of its oral GLP-1 receptor agonist, GSBR-1290, in overweight patients. … Continue Reading
Read now
Transcript Immunovant (IMVT) IMVT-1402 Phase 1 SAD & MAD Results
Transcripts - Operator Good morning. My name is Michelle, and I’m your conference call operator. As a reminder, this call is being recorded. Before we begin, I … Continue Reading
Read now
Transcript: Soleno (SLNO) Data of DCCR for Prader-Willi Syndrome
Transcripts - Operator Greetings. Welcome to Soleno Therapeutics Randomized Withdrawal Period of Study C602 Top Line Results. [Operator Instructions] Please note, this conference is being recorded.At this … Continue Reading
Read now
Transcript: Cardiff (CRDF) Phase 2 Onvansertib Data in Pancreatic & SCLC
Transcripts - Operator Welcome to the Cardiff Oncology Clinical Development Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, Tuesday, September 26, … Continue Reading
Read now